ROTHBLATT MARTINE A (Chairperson & CEO) sold 19.0% of their position (9.50K shares) of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $5.26M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+9.50K
Price / share
$146.03
Trade value
$1.39M
% of position
Common Stock
Shares
−280.00
Price / share
$548.60
Trade value
$153.61K
% of position
Common Stock
Shares
−769.00
Price / share
$549.59
Trade value
$422.64K
% of position
Common Stock
Shares
−1.60K
Price / share
$550.60
Trade value
$883.71K
% of position
Common Stock
Shares
−986.00
Price / share
$551.34
Trade value
$543.62K
% of position
Common Stock
Shares
−680.00
Price / share
$552.58
Trade value
$375.75K
% of position
Common Stock
Shares
−823.00
Price / share
$553.73
Trade value
$455.72K
% of position
Common Stock
Shares
−817.00
Price / share
$554.57
Trade value
$453.08K
% of position
Common Stock
Shares
−1K
Price / share
$555.59
Trade value
$555.59K
% of position
Common Stock
Shares
−461.00
Price / share
$556.67
Trade value
$256.62K
% of position
Common Stock
Shares
−918.00
Price / share
$557.80
Trade value
$512.06K
% of position
Common Stock
Shares
−841.00
Price / share
$558.81
Trade value
$469.96K
% of position
Common Stock
Shares
−320.00
Price / share
$559.41
Trade value
$179.01K
% of position
Net shares
+0.00
Net value
-$3.87M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/29/2026 | M · Option Exercise | +9.50K | $146.03 | $1.39M | 23.4% | 40.51K | 50.01K |
| Common Stock Direct | 5/29/2026 | S · Sale | −280.00 | $548.60 | $153.61K | 0.6% | 50.01K | 49.73K |
| Common Stock Direct | 5/29/2026 | S · Sale | −769.00 | $549.59 | $422.64K | 1.5% | 49.73K | 48.96K |
| Common Stock Direct | 5/29/2026 | S · Sale | −1.60K | $550.60 | $883.71K | 3.3% | 48.96K | 47.36K |
| Common Stock Direct | 5/29/2026 | S · Sale | −986.00 | $551.34 | $543.62K | 2.1% | 47.36K | 46.37K |
| Common Stock Direct | 5/29/2026 | S · Sale | −680.00 | $552.58 | $375.75K | 1.5% | 46.37K | 45.69K |
| Common Stock Direct | 5/29/2026 | S · Sale | −823.00 | $553.73 | $455.72K | 1.8% | 45.69K | 44.87K |
| Common Stock Direct | 5/29/2026 | S · Sale | −817.00 | $554.57 | $453.08K | 1.8% | 44.87K | 44.05K |
| Common Stock Direct | 5/29/2026 | S · Sale | −1K | $555.59 | $555.59K | 2.3% | 44.05K | 43.05K |
| Common Stock Direct | 5/29/2026 | S · Sale | −461.00 | $556.67 | $256.62K | 1.1% | 43.05K | 42.59K |
| Common Stock Direct | 5/29/2026 | S · Sale | −918.00 | $557.80 | $512.06K | 2.2% | 42.59K | 41.67K |
| Common Stock Direct | 5/29/2026 | S · Sale | −841.00 | $558.81 | $469.96K | 2.0% | 41.67K | 40.83K |
| Common Stock Direct | 5/29/2026 | S · Sale | −320.00 | $559.41 | $179.01K | 0.8% | 40.83K | 40.51K |
| Total | +0.00 | -$3.87M | ||||||
Stock Option
Common Stock
9.50K shares
Shares
−9.50K
Strike price
146.03
Held after
135.91K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock9.50K shares | 5/29/2026 | M · Option Exercise | −9.50K | 146.03 | — | 135.91K |
Common Stock
IndirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 166.00 | Indirect |
| Common Stock | 45.60K | Indirect |
| Common Stock | 8.90K | Indirect |
| Common Stock | 324.44K | Indirect |
| Common Stock | 249.11K | Indirect |
| Total | 628.22K | 628.22K indirect |